Esophagogastric Tumors
1 clinical trials · Condition
◉ Watch Esophagogastric Tumors
| Record | Firm | Date |
|---|---|---|
| A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection (NCT04510285) | Memorial Sloan Kettering Cancer Center | 2020-08-10 |
Track Esophagogastric Tumors automatically
Every clearance here is in the API, with alerts when new ones post.